DRH1 – a novel blood-based HPV tumour marker

BACKGROUND: To date, no studies have successfully shown that a highly specific, blood-based tumour marker to detect clinically relevant HPV-induced disease could be used for screening, monitoring therapy response or early detection of recurrence. This study aims to assess the clinical performance of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EBioMedicine
Hlavní autoři: Weiland, Thomas, Eckert, Alexander, Tomazic, Peter Valentin, Wolf, Axel, Pondorfer, Prisca, Vasicek, Sarah, Graupp, Matthias, Holzmeister, Clemens, Moser, Ulrich, Andrianakis, Alexandros, Kangler, Georg, Kiss, Peter, Brcic, Luka, Kappler, Matthias, Wickenhauser, Claudia, Haak, Anja, Krüger, Maximilian, Al-Nawas, Bilal, Blatt, Sebastian, Brockmeyer, Norbert, Skaletz-Rorowski, Adriane, Potthoff, Anja, French, Lars E., Charnowski, Sara, Reinholz, Markus, Kaufmann, Andreas M., Thies, Sarah, Lambrecht, Hans-Georg, Seliger, Barbara, Wild, Dominik C., Thurnher, Dietmar
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2020
Témata:
Research paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300133/
https://ncbi.nlm.nih.gov/pubmed/32535546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102804
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky